Allucent

Allucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies. With over 30 years of background in regulatory trends, therapeutic experience, and operational expertise, the company partners with biopharma to advance therapies through every phase of drug development and clinical trials from early-stage to post-approval.

Therapeutic Expertise

Allucent focuses on deep expertise in:

• Oncology & Hematology — including antibody-drug conjugates (ADCs)
• Neuroscience — with insights into neurodegenerative disorders and disease-modifying therapies
• Infectious Disease & Vaccine development
• Immunology and Inflammation
• Cardiometabolic Disease
• Allergy & Asthma
• Cell & Gene Therapy
• Rare Diseases
• Pediatrics

Core Service Offerings

Clinical Development & Operations:

• Clinical trial start-up and site intelligence
• Patient recruitment and retention
• Decentralized clinical trials
• Data management and biostatistics
• Medical monitoring and clinical pharmacology
• Clinical trial safety and post-marketing pharmacovigilance

Drug Development Strategy:

• Regulatory strategy and product development
• CMC and preclinical support
• IND and NDA submissions
• Orphan drug designation and pediatric investigation plans
• Modeling and simulation
• End-to-end pharmacokinetics
• Embedded pharmacologist services

Regulatory & Safety:

• Regulatory submissions and strategy
• GxP consulting
• Drug safety and pharmacovigilance
• Government and public health services

Preclinical Capabilities:

• In vitro and in vivo studies
• Cell therapy manufacturing analytical testing and validation

Allucent combines deep therapeutic expertise with a nimble, collaborative approach, offering flexible regulatory solutions and scientific insight to help biopharma accelerate development, overcome complexity, and deliver innovative treatments to patients worldwide.